Design, docking optimization, and evaluation of biotin-PEG4-1,8-naphthalimide as a potent and safe antitumor agent with dual targeting of ferroptosis and DNA-Reference-Cited by-同舟云学术

Design, docking optimization, and evaluation of biotin-PEG4-1,8-naphthalimide as a potent and safe antitumor agent with dual targeting of ferroptosis and DNA

Published:2024 Issue:5 Volume:15 Page:1640-1651
ISSN:2632-8682
Container-title:RSC Medicinal Chemistry
language:en
Short-container-title:RSC Med. Chem.

Author:

Wang Qi¹²³,Liang Si-Min¹²³,Mao Zhi-Chen¹²³,Ma Xian-Li¹²³,Wei Jian-Hua¹²³,Huang Ri-Zhen¹,Zhang Ye¹²^ORCID

Affiliation:

1. Guangxi Key Laboratory of Drug Discovery and Optimization, School of Pharmacy, Guilin Medical University, Guilin 541004, China

2. Guangxi Engineering Research Center for Pharmaceutical Molecular Screening and Druggability Evaluation, School of Pharmacy, Guilin Medical University, Guilin 541004, China

3. Key Laboratory of Medical Biotechnology and Translational Medicine, School of Pharmacy, Guilin Medical University, Guilin 541004, China

Abstract

A set of biotin-polyethylene glycol (PEG)-naphthalimide derivatives 4a–4h with dual targeting of ferroptosis and DNA were designed and optimized using docking simulation as antitumor agents.

Funder

National Natural Science Foundation of China

Natural Science Foundation of Guangxi Zhuang Autonomous Region

Guilin Scientific Research and Technology Development Plan

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/MD/D4MD00134F

Reference33 articles.

1. Cancer statistics, 2022

2. The Hallmarks of Cancer

3. Accelerating the understanding of cancer biology through the lens of genomics

4. Rational Multitargeted Drug Design Strategy from the Perspective of a Medicinal Chemist

5. Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds